Innophos Holdings, Inc. (NASDAQ:IPHS) has been given an average broker rating score of 3.00 (Hold) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a hold rating.
Zacks has also assigned Innophos an industry rank of 226 out of 255 based on the ratings given to its competitors.
IPHS has been the subject of several analyst reports. BidaskClub downgraded shares of Innophos from a “sell” rating to a “strong sell” rating in a research note on Saturday, November 10th. Zacks Investment Research downgraded shares of Innophos from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 25th. Finally, ValuEngine raised shares of Innophos from a “strong sell” rating to a “sell” rating in a research note on Monday, February 4th.
Institutional investors and hedge funds have recently bought and sold shares of the business. Deprince Race & Zollo Inc. grew its holdings in shares of Innophos by 40.7% during the 4th quarter. Deprince Race & Zollo Inc. now owns 612,289 shares of the specialty chemicals company’s stock worth $15,019,000 after purchasing an additional 177,149 shares during the period. Northpointe Capital LLC boosted its holdings in Innophos by 2,069.0% in the 3rd quarter. Northpointe Capital LLC now owns 169,140 shares of the specialty chemicals company’s stock worth $7,510,000 after acquiring an additional 161,342 shares during the period. Assenagon Asset Management S.A. purchased a new position in Innophos in the 4th quarter worth approximately $3,847,000. BlackRock Inc. boosted its holdings in Innophos by 5.1% in the 3rd quarter. BlackRock Inc. now owns 2,800,584 shares of the specialty chemicals company’s stock worth $124,346,000 after acquiring an additional 134,916 shares during the period. Finally, American Century Companies Inc. boosted its holdings in Innophos by 15.8% in the 3rd quarter. American Century Companies Inc. now owns 726,190 shares of the specialty chemicals company’s stock worth $32,243,000 after acquiring an additional 99,315 shares during the period. Institutional investors own 93.11% of the company’s stock.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Recommended Story: What are the benefits of momentum investing?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.